It is reported that SIRT1 is increased in many human tumors, such as breast cancer [10], ovarian cancer [11], prostate cancer [12], gastric cancer [13], colon cancer [14], diffuse large B-cell lymphoma [15], acute myeloid leukemia [16] and Bowen’s disease [17]. Here, SIRT1 is linked to prostate carcinoma.